Clinical Trial Update: Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of co-administered JW0104 and C2402 in patients with hypertension and dyslipidemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• C2402
• JW0104

Snippet

Sponsor: JW Pharmaceutical | Conditions: Hypertension, Dyslipidemia | Phase 3 | Status: RECRUITING